Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Serreen F. Meki
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Robotics/AI Company Agrees to Seven-Figure False Claims Act Settlement

May 7, 2025 | False Claims Act, Fraud Investigations, Government Contract, Government Investigations

On May 5, 2025, the Department of Justice (United States Attorney’s Office, Northern District of California) announced that San Jose-based robotics/AI company Vimaan Robotics agreed to pay $1.5 million to resolve allegations that it violated the federal False...

DOJ Inks $202 Million False Claims Act Settlement Involving Gilead’s Physician Speaker Program

Apr 30, 2025 | False Claims Act, Health Care, Health Care Fraud

On April 29, 2025, the U.S. Department of Justice (United States Attorney’s Office, Southern District of New York) announced that pharmaceutical giant Gilead Sciences agreed to pay a whopping $202 Million to resolve a False Claims Act investigation.  At issue...

New Tariffs Likely to Bring Increase in Customs Fraud Enforcement

Feb 2, 2025 | False Claims Act, federal investigations, Fraud Investigations, Government Investigations

On February 1, 2025, President Trump announced the imposition of substantial tariffs on goods imported from Canada, Mexico, and China.  These tariffs are likely to come with an increase in customs enforcement, with customs officials ensuring that incoming goods are...

Virginia Hospital Indicted for Fraud

Jan 31, 2025 | Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, White Collar Crime

Earlier this month, the Department of Justice announced that it had indicted the Chesapeake Regional Medical Center (CRMC) with healthcare fraud and conspiracy in relation to unnecessary gynecological and other procedures performed by one of its employed physicians....

Pharmaceutical Giant Teva Agrees to Pay $450 Million to Resolve False Claims Act and Antitrust Matters

Oct 14, 2024 | False Claims Act, Health Care, Health Care Fraud, White Collar Crime

On October 10, 2024, the DOJ announced that Teva Pharmaceuticals had agreed to pay $450 million to resolve two matters, one of which was the result of an investigation conducted pursuant to the False Claims Act (FCA). According to the DOJ, the settlement encompasses...
« Older Entries

Recent Posts

  • Are the False Claims Act’s Qui Tam Provisions Constitutional? Another Court Weighs In
  • Popular Restaurant Chain Pays $7.8 Million to Resolve Pandemic-Related False Claims Act Case
  • Robotics/AI Company Agrees to Seven-Figure False Claims Act Settlement
  • The Forge Returns: Entitled Downtown Site Poised for Mixed-Use Revival
  • Louisiana Nurse Convicted of DME Fraud Scheme

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group